• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952820300
Device Problem Occlusion Within Device (1423)
Patient Problems Dyspnea (1816); Ischemia (1942); Reocclusion (1985); Ventricular Tachycardia (2132)
Event Date 04/14/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that in-stent restenosis occurred.In (b)(6) 2015, clinical assessment indicated that the patient's qualifying conditions stress test strongly positive with severe st depression in the recovery phase, and the medical history of coronary artery disease with prior percutaneous coronary intervention (pci) and coronary artery bypass graft (cabg.On the same day the patient underwent elective percutaneous coronary intervention (pci).The target lesion was a de novo lesion located in the left main coronary artery (lmca) with 99% stenosis.It involved the left circumflex (lcx).It was 18mm long, with a reference vessel diameter of 3.0mm.The thrombolysis in myocardial infarction (timi) flow was 0.The target lesion was treated with pre-dilatation with a 2.5mm balloon at 18 atmospheres and insertion of a 3.00x20mm promus premier everolimus-eluting platinum chromium coronary stent.Post-dilatation was not performed.There was 0% residual stenosis and the timi flow was improved to 3.The following day, the patient subject was discharged on aspirin and clopidogrel.In (b)(6) 2016, the patient was diagnosed with 99% in stent restenosis when the patient experienced shortness of breath, silent ischemia, non-sustained ventricular tachycardia, and inferoseptal and anterior wall hypokinesis, with nuclear exercise stress testing.Oxygen saturation on room air was 99%.There was no peripheral edema and no wheezes or rales.The patient underwent pci of the target lesion at the ostium of the lcx.Pre-dilatation was performed with a 3x10mm sculpting balloon, followed by insertion of a 3.0x22mm non bsc drug eluting stent (des).It was deployed at 16 atmospheres.Post dilatation was performed with a 3.5mm high-pressure balloon (hpb).The post-procedural stenosis was 0%.The re-stenting was successful, without complication and post-treatment timi flow was 3.On the same day, the event was considered resolved the patient was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5646833
MDR Text Key44992594
Report Number2134265-2016-03985
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/18/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/26/2016
Device Model NumberH7493952820300
Device Catalogue Number39528-2030
Device Lot Number17245108
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/18/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/15/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-